• 主题
高级搜索  >
历史搜索 清空历史
首页> 外国专利> RECOMBINANT PLASMID DNA PROCESSING A9, ENCODING THE SYNTHESIS OF PROTEIN WITH ANTIGENIC PROPERTIES OF HUMAN DEFICIENCY VIRUS OF THE FIRST TYPE, METHOD FOR ITS CONSTRUCTION, AND THE STRAIN OF BACTERIA ESCHERICHIA COLI - A PRODUCER OF PROTEIN WITH ANTIGENIC PROPERTIES OF HUMAN IMMUNE DEFICIENCY VIRUS OF THE FIRST TYPE

RECOMBINANT PLASMID DNA PROCESSING A9, ENCODING THE SYNTHESIS OF PROTEIN WITH ANTIGENIC PROPERTIES OF HUMAN DEFICIENCY VIRUS OF THE FIRST TYPE, METHOD FOR ITS CONSTRUCTION, AND THE STRAIN OF BACTERIA ESCHERICHIA COLI - A PRODUCER OF PROTEIN WITH ANTIGENIC PROPERTIES OF HUMAN IMMUNE DEFICIENCY VIRUS OF THE FIRST TYPE

机译：重组质粒DNA处理A9，编码具有第一型人类缺陷病毒抗原特性的蛋白质，其构建方法和大肠杆菌菌株-带有人类免疫缺陷病毒抗原特性的蛋白质的生产者第一类

页面导航
  • 摘要
  • 著录项
  • 相似文献

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to medicine and biotechnology. the purpose is to improve the service u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 trust product. in u043fu043bu0430u0437u043cu0438u0434u0443 pG30 introduced EcoW - u0435u0441u043eu0436 - frag a dna plasmid u0440u0430u043a25 containing rug - locus for the stable inheritance of hybrid plasmids pGA9, u043au043eu0442u043eu0440u0430u00a0 has be r 7.9 u0442.u043f.u043d.u043fu043bu0430u0437u043cu0438u0434u0430 pGAQ has unique restriction sites, BamHI, sail, u043eu043fu0440u0435u0434u0435u043bu00a0u0435u0442 resistance to u0430u043cu043fu0438u0446u0438u043bu043bu0438u043du0443 and u043au0430u043du0430u043cu0438u0446u0438u043du0443, u043du0435u043au043eu043du044cu044eu0433u0430u0442u0438u0432u043du0430, encodes the fusion protein with.u0430u043du0442 u0438u0433u0435u043du043du044bu043cu0438 properties of human immunodeficiency virus type 1 (hiv 1). u043fu043bu0430u0437u043cu0438u0434u0443 - pGA9 u0432u0432u043eu0434u00a0u0442 in strain of e.soy u043du0432101 by u0442u0440u0430u043du0441u00ab | & & amp; u043eu0440u043cu0430u0446u0438u0438 receive strain for protein synthesis in the amount of $650, 750 mg / ml protein, n is the end part of which is provided u043fu043eu043bu043du043eu0440u0430u0437 u0432u0430u00a0 beta u0433u0430u043bu0430u043au0442u043eu0437u0438u0434u0430u0437u043eu0439 dose measuring device, and the end product is u0431u0438u0440u0443u0441u0441u043fu0435u0446u0438u0444u0438u0447u0435u0441u043au043eu0439 sequence gene gag, a u0430u043du0442u0438u0433u0435u043du043du044bu043cu0438 properties of hiv 1. 3 u0441.u043f.u0444 - lu (hp.
机译：发明涉及医学和生物技术领域的发明。目的是改善服务 u0438 u0437 u043e u0431 u0440 u0435 u0442 u0435 u043d u0438 u00a0信任产品。在 u043f u043b u0430 u0437 u043c u0438 u0434 u0443 pG30中引入了EcoW- u0435 u0441 u043e u0436-使含有rug的dna质粒 u0440 u0430 u043a25片段-稳定杂交的基因座质粒pGA9， u043a u043e u0442 u043e u0440 u0430 u00a0为r 7.9 u0442。 u043f。 u043d。 u043f u043b u0430 u0437 u043c u043c u0438 u0434 u0430 u0430站点，BamHI，帆， u043e u043f u0440 u0435 u0434 u0435 u043b u00a0 u0435 u0442对 u0430 u043c u043f u0438 u0446 u0438 u043b u043b u043b u0438 u043d u0443的抵抗力和 u043a u0430 u043d u0430 u043c u0438 u0446 u0438 u043d u0443， u043d u0435 u043a u043e u043d u043d u044c u044e u0433 u0430 u0430 u0442 u0438 u0432 u043d u043d编码融合蛋白，其类型为1型人类免疫缺陷病毒（hiv 1）。 u0430 u043d u0442 u0438 u0433 u0435 u043d u043d u044b u043c u0438属性。 u043f u043b u0430 u0437 u043c u0438 u0434 u0443-由 u0442 u042 u0440 u0430 u043d 产生的e.soy u043d u0432101菌株中的pGA9 u0432 u0432 u043e u0434 u00a0 u0442 u0441 u00ab | ＆ ＆amp; u043e u0440 u043c u0430 u0446 u0438 u0438接受650美元的750毫克/毫升蛋白质的蛋白质合成菌株，其中n为末端，提供 u043f u043e u043b u043d u043e u0440 u0430 u0437 u0432 u0430 u00a0 beta u0433 u0430 u043b u0430 u043a u0442 u043e u0437 u0438 u0434 u0430 u0437 u043e u0439剂量测量装置和最终产品是 u0431 u0438 u0440 u0443 u0441 u0441 u043f u0435 u0446 u0438 u0444 u0438 u0447 u0435 u0441 u043a u043e u0439序列基因gag， u0430 u043d u0442 u0438 u0433 u0435 u043d u043d u044b u043c u0438的属性。1。3 u0441。 u043f。 u0444-lu（hp。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号